交易 Aytu BioScience, Inc. - AYTU CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.218 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 0.01 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Aytu Biopharma Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 17, 2024 | 2.726 | -0.030 | -1.09% | 2.756 | 2.856 | 2.706 |
Apr 16, 2024 | 2.756 | 0.100 | 3.77% | 2.656 | 2.846 | 2.566 |
Apr 15, 2024 | 2.666 | -0.120 | -4.31% | 2.786 | 2.846 | 2.566 |
Apr 12, 2024 | 2.786 | -0.270 | -8.84% | 3.056 | 3.076 | 2.696 |
Apr 11, 2024 | 3.066 | 0.030 | 0.99% | 3.036 | 3.136 | 3.026 |
Apr 10, 2024 | 3.126 | -0.090 | -2.80% | 3.216 | 3.266 | 3.046 |
Apr 9, 2024 | 3.296 | 0.080 | 2.49% | 3.216 | 3.316 | 3.216 |
Apr 8, 2024 | 3.266 | 0.360 | 12.39% | 2.906 | 3.286 | 2.846 |
Apr 5, 2024 | 3.146 | 0.120 | 3.97% | 3.026 | 3.196 | 3.026 |
Apr 4, 2024 | 3.136 | 0.230 | 7.91% | 2.906 | 3.186 | 2.876 |
Apr 3, 2024 | 2.936 | 0.040 | 1.38% | 2.896 | 3.106 | 2.896 |
Apr 2, 2024 | 2.966 | 0.080 | 2.77% | 2.886 | 3.006 | 2.886 |
Apr 1, 2024 | 2.946 | -0.010 | -0.34% | 2.956 | 3.096 | 2.916 |
Mar 28, 2024 | 3.006 | 0.050 | 1.69% | 2.956 | 3.106 | 2.926 |
Mar 27, 2024 | 2.926 | -0.040 | -1.35% | 2.966 | 3.016 | 2.846 |
Mar 26, 2024 | 2.966 | -0.040 | -1.33% | 3.006 | 3.076 | 2.886 |
Mar 25, 2024 | 3.036 | 0.000 | 0.00% | 3.036 | 3.106 | 3.036 |
Mar 22, 2024 | 2.876 | -0.030 | -1.03% | 2.906 | 2.976 | 2.786 |
Mar 21, 2024 | 2.956 | 0.080 | 2.78% | 2.876 | 2.986 | 2.826 |
Mar 20, 2024 | 2.846 | 0.110 | 4.02% | 2.736 | 2.906 | 2.696 |
Aytu BioScience, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 9, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q3 2024 Aytu Biopharma Inc Earnings Release Q3 2024 Aytu Biopharma Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, May 17, 2024 | ||
時間 (UTC) 16:00 | 國家 US
| 事件 Aytu Biopharma Inc Annual Shareholders Meeting Aytu Biopharma Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Wednesday, September 25, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q4 2024 Aytu Biopharma Inc Earnings Release Q4 2024 Aytu Biopharma Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
總收入 | 107.399 | 96.669 | 65.632 | 27.6321 | 7.32036 |
收入 | 107.399 | 96.669 | 65.632 | 27.6321 | 7.32036 |
收入成本,共計 | 40.767 | 44.386 | 36.432 | 7.55303 | 2.20204 |
毛利 | 66.632 | 52.283 | 29.2 | 20.0791 | 5.11832 |
總營業費用 | 124.464 | 206.406 | 126.071 | 38.6481 | 33.9975 |
銷售/一般/行政費用,總計 | 70.078 | 69.88 | 55.808 | 34.8024 | 19.2396 |
研究與開發 | 4.095 | 12.662 | 5.623 | 1.72142 | 0.58907 |
Depreciation / Amortization | 4.788 | 5.844 | 6.009 | 4.49047 | 2.13626 |
異常費用(收入) | 5.705 | 75.289 | 22.199 | -9.91925 | 9.83055 |
營業收入 | -17.065 | -109.737 | -60.439 | -11.016 | -26.6772 |
利息收入(費用),非經營淨值 | 0.014 | -0.757 | -2.05 | -2.60466 | -0.45472 |
稅前淨收入 | -17.051 | -108.889 | -58.03 | -13.6207 | -27.1319 |
稅後淨收入 | -17.051 | -108.779 | -58.289 | -13.6207 | -27.1319 |
未計算非常項目前的淨收益 | -17.051 | -108.779 | -58.289 | -13.6207 | -27.1319 |
淨收入 | -17.051 | -108.779 | -58.289 | -13.6207 | -27.1319 |
普通股股東可獲收益 (不含非經常性項目) | -17.051 | -108.779 | -58.289 | -13.6207 | -27.1319 |
普通股股東可獲收益 (含非經常性項目) | -17.051 | -108.779 | -58.289 | -13.6207 | -27.1319 |
攤薄淨收入 | -17.051 | -108.779 | -58.289 | -13.6207 | -27.1319 |
攤薄後加權平均股 | 3.33991 | 1.46988 | 0.83733 | 0.22596 | 0.03897 |
扣除特別項目的每股攤薄盈利 | -5.10523 | -74.0056 | -69.6126 | -60.2791 | -696.182 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -3.3971 | -40.7117 | -52.3801 | -104.177 | -443.938 |
非常規項目總計 | |||||
其他,淨值 | 1.605 | 4.459 | |||
Other Operating Expenses, Total | -0.969 | -1.655 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 30.732 | 22.733 | 26.279 | 27.655 | 27.448 |
收入 | 30.732 | 22.733 | 26.279 | 27.655 | 27.448 |
收入成本,共計 | 12.168 | 9.99 | 8.986 | 9.623 | 12.606 |
毛利 | 18.564 | 12.743 | 17.293 | 18.032 | 14.842 |
總營業費用 | 30.563 | 31.291 | 33.072 | 29.308 | 44.388 |
銷售/一般/行政費用,總計 | 14.095 | 19.981 | 18.578 | 17.424 | 17.395 |
研究與開發 | 0.465 | 0.856 | 1.71 | 1.064 | 3.253 |
Depreciation / Amortization | 1.195 | 1.198 | 1.198 | 1.197 | 1.298 |
異常費用(收入) | 3.105 | 0 | 2.6 | 10.809 | |
營業收入 | 0.169 | -8.558 | -6.793 | -1.653 | -16.94 |
利息收入(費用),非經營淨值 | -2.626 | 1.358 | 0.1 | 1.08 | -0.761 |
其他,淨值 | -0.128 | 1.612 | |||
稅前淨收入 | -2.457 | -7.2 | -6.693 | -0.701 | -16.089 |
稅後淨收入 | -2.457 | -7.2 | -6.693 | -0.701 | -16.089 |
未計算非常項目前的淨收益 | -2.457 | -7.2 | -6.693 | -0.701 | -16.089 |
淨收入 | -2.457 | -7.2 | -6.693 | -0.701 | -16.089 |
普通股股東可獲收益 (不含非經常性項目) | -2.457 | -7.2 | -6.693 | -0.701 | -16.089 |
普通股股東可獲收益 (含非經常性項目) | -2.457 | -7.2 | -6.693 | -0.701 | -16.089 |
攤薄淨收入 | -2.457 | -7.2 | -6.693 | -0.701 | -16.089 |
攤薄後加權平均股 | 4.06223 | 3.72678 | 3.1103 | 2.51791 | 2.73622 |
扣除特別項目的每股攤薄盈利 | -0.60484 | -1.93196 | -2.15188 | -0.27841 | -5.88 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
每股正常攤薄盈利 | 0.15952 | -1.93196 | -1.31595 | -0.27841 | -1.92967 |
Other Operating Expenses, Total | -0.465 | -0.734 | -0.973 |
- 每年
- 每季度
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
流動資産總額 | 72.832 | 59.929 | 105.234 | 75.4226 | 15.4329 |
現金和短期投資 | 22.985 | 19.36 | 49.649 | 48.0817 | 11.0442 |
現金等價物 | 22.985 | 19.36 | 49.649 | 48.0817 | 11.0442 |
短期投資 | |||||
應收賬款總額,淨額 | 28.937 | 21.712 | 28.176 | 5.63272 | 1.74079 |
應收賬款 - 貿易,淨額 | 28.937 | 21.712 | 28.176 | 5.63272 | 1.74079 |
總庫存 | 11.995 | 10.849 | 16.339 | 9.99944 | 1.44007 |
預付的費用 | 8.047 | 7.375 | 9.78 | 5.71509 | 0.95778 |
總資産 | 136.463 | 137.623 | 265.668 | 153.293 | 34.7214 |
物業/廠房/設備,總計 - 淨額 | 3.869 | 6.296 | 8.703 | 0.89261 | 0.20373 |
商譽,淨額 | 0 | 65.802 | 28.0904 | ||
無形資産,淨額 | 58.97 | 70.632 | 85.464 | 48.8546 | 19.0826 |
其他長期資産,總計 | 0.792 | 0.766 | 0.465 | 0.03298 | 0.0022 |
流動負債總額 | 69.015 | 64.442 | 109.438 | 28.7634 | 5.37258 |
Payable/Accrued | 11.012 | 9.468 | 8.689 | 0.959 | |
預提費用 | 37.045 | 35.946 | 49.485 | 11.1046 | 1.99724 |
應付票據/短期債務 | 1.563 | 3.813 | 7.934 | 0 | 0 |
其他流動負債,總計 | 5.832 | 4.132 | 7.407 | 4.87523 | 1.07807 |
負債總額 | 97.106 | 91.531 | 128.1 | 58.2778 | 27.6336 |
長期債務總額 | 14.713 | 14.279 | 0.18 | 0 | 0 |
其他負債,總計 | 13.378 | 12.81 | 18.482 | 29.5145 | 22.261 |
股權 | 39.357 | 46.092 | 137.568 | 95.0153 | 7.08782 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0.00036 |
普通股 | 0.001 | 0.004 | 0.003 | 0.00126 | 0.00175 |
額外實收資本 | 343.485 | 334.56 | 315.864 | 215.024 | 113.475 |
留存收益(累計赤字) | -304.129 | -288.472 | -178.299 | -120.01 | -106.39 |
總負債和股東權益 | 136.463 | 137.623 | 265.668 | 153.293 | 34.7214 |
已發行普通股總數 | 5.51717 | 1.92894 | 1.37452 | 0.62919 | 0.08769 |
其他流動資産,總計 | 0.868 | 0.633 | 1.29 | 5.9936 | 0.25 |
應付賬款 | 13.478 | 10.987 | 19.255 | 11.8246 | 2.29727 |
物業/廠房/設備,總計 - 總額 | 7.55 | 8.717 | 9.715 | 1.37661 | 0.59973 |
累計折舊,總計 | -3.681 | -2.421 | -1.012 | -0.484 | -0.396 |
Total Preferred Shares Outstanding | 0 | 0 | 3.59498 | ||
長期債務的當前部分/資本租賃 | 0.085 | 0.096 | 16.668 | 0 | |
資本租賃義務 | 0 | 0.084 | 0.18 | 0 | |
長期債務 | 14.713 | 14.195 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 70.599 | 72.832 | 78.465 | 70.611 | 74.415 |
現金和短期投資 | 19.964 | 22.985 | 19.179 | 19.501 | 23.811 |
現金等價物 | 19.964 | 22.985 | 19.179 | 19.501 | 23.811 |
應收賬款總額,淨額 | 29.882 | 28.937 | 34.043 | 25.547 | 27.924 |
應收賬款 - 貿易,淨額 | 29.882 | 28.937 | 34.043 | 25.547 | 27.924 |
總庫存 | 12.966 | 11.995 | 13.637 | 12.95 | 12.871 |
預付的費用 | 7.038 | 8.047 | 10.429 | 11.989 | 9.024 |
其他流動資産,總計 | 0.749 | 0.868 | 1.177 | 0.624 | 0.785 |
總資産 | 132.888 | 136.463 | 147.216 | 141.436 | 150 |
物業/廠房/設備,總計 - 淨額 | 4.176 | 3.869 | 4.395 | 5.019 | 5.648 |
物業/廠房/設備,總計 - 總額 | 8.166 | 7.55 | 7.779 | 8.083 | 8.384 |
累計折舊,總計 | -3.99 | -3.681 | -3.384 | -3.064 | -2.736 |
商譽,淨額 | |||||
無形資産,淨額 | 57.341 | 58.97 | 63.464 | 64.985 | 69.108 |
其他長期資産,總計 | 0.772 | 0.792 | 0.892 | 0.821 | 0.829 |
流動負債總額 | 65.463 | 69.015 | 85.416 | 67.15 | 73.204 |
應付賬款 | 14.466 | 13.478 | 14.673 | 10.58 | 14.667 |
Payable/Accrued | 13.023 | 11.012 | 10.287 | 9.137 | 8.08 |
預提費用 | 28.972 | 37.045 | 40.55 | 33.326 | 34.603 |
應付票據/短期債務 | 1.215 | 1.563 | 10.403 | 7.429 | 8.087 |
長期債務的當前部分/資本租賃 | 0.062 | 0.085 | 3.305 | 0.09 | 0.925 |
其他流動負債,總計 | 7.725 | 5.832 | 6.198 | 6.588 | 6.842 |
負債總額 | 100.721 | 97.106 | 106.304 | 95.619 | 96.094 |
長期債務總額 | 14.842 | 14.713 | 11.386 | 14.533 | 13.56 |
長期債務 | 14.842 | 14.713 | 11.371 | 14.494 | 13.498 |
資本租賃義務 | 0 | 0.015 | 0.039 | 0.062 | |
其他負債,總計 | 20.416 | 13.378 | 9.502 | 13.936 | 9.33 |
股權 | 32.167 | 39.357 | 40.912 | 45.817 | 53.906 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.001 | 0.001 | 0.00038 | 0.00034 | 0.006 |
額外實收資本 | 344.415 | 343.485 | 342.584 | 340.289 | 345.253 |
留存收益(累計赤字) | -312.249 | -304.129 | -301.672 | -294.472 | -291.353 |
總負債和股東權益 | 132.888 | 136.463 | 147.216 | 141.436 | 150 |
已發行普通股總數 | 5.53024 | 5.51717 | 3.77951 | 3.38315 | 3.12147 |
Total Preferred Shares Outstanding | |||||
其他權益,總計 | -0.00038 | -0.00034 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -110.173 | -58.289 | -13.6207 | -27.1319 | -10.1879 |
經營活動産生的現金 | -28.823 | -25.964 | -28.3739 | -13.8314 | -15.9403 |
經營活動産生的現金 | 10.251 | 9.201 | 6.24583 | 2.72707 | 2.59127 |
Deferred Taxes | |||||
非現金物品 | 81.962 | 21.443 | -8.38913 | 10.7837 | -7.62492 |
營運資金的變化 | -10.863 | 1.681 | -12.6099 | -0.2102 | -0.71881 |
投資活動産生的現金 | -3.248 | -2.782 | -5.65577 | -1.06199 | -0.48429 |
資本支出 | -2.341 | 0 | -0.05985 | -0.07471 | |
其他投資現金流量項目,總計 | -3.248 | -0.441 | -5.65577 | -1.00214 | -0.40959 |
融資活動産生的現金 | 1.53 | 30.314 | 71.0687 | 19.0751 | 22.6596 |
融資現金流項目 | -4.942 | -10.996 | -5.40415 | -1.47996 | -2.75752 |
股票的發行(報廢),淨額 | 11.694 | 45.051 | 92.7217 | 15.555 | 25.4171 |
債務的發行(退還),淨額 | -5.222 | -3.741 | -16.2488 | 5 | |
現金淨變化 | -30.541 | 1.568 | 37.0391 | 4.1817 | 6.23499 |
已付現金利息 | 3.148 | 1.249 | 1.04028 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -14.594 | -7.394 | -2.881 | -110.173 | -92.472 |
Cash From Operating Activities | -14.494 | -11.588 | -9.148 | -28.823 | -21.728 |
Cash From Operating Activities | 6.699 | 4.505 | 2.328 | 10.251 | 8.005 |
Non-Cash Items | 1.658 | 3.846 | 1.488 | 81.962 | 67.39 |
Cash Interest Paid | 2.861 | 2.021 | 0.565 | 3.148 | 3.08 |
Changes in Working Capital | -8.257 | -12.545 | -10.083 | -10.863 | -4.651 |
Cash From Investing Activities | 0.038 | 0.037 | 0.042 | -3.248 | -3.207 |
Other Investing Cash Flow Items, Total | 0.038 | 0.037 | 0.042 | -3.248 | -3.207 |
Cash From Financing Activities | 14.275 | 11.692 | 13.557 | 1.53 | 2.647 |
Financing Cash Flow Items | -5.254 | -3.497 | -1.107 | -4.942 | -4.429 |
Issuance (Retirement) of Stock, Net | 13.012 | 11.573 | 10.416 | 11.694 | 12.7 |
Issuance (Retirement) of Debt, Net | 6.517 | 3.616 | 4.248 | -5.222 | -5.624 |
Net Change in Cash | -0.181 | 0.141 | 4.451 | -30.541 | -22.288 |
Capital Expenditures |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Pharmaceuticals (NEC) |
7900 E. Union Avenue
Suite 920
DENVER
COLORADO 80237
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易